Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults-Reference-Cited by-同舟云学术

Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults

Published:2017-11-09 Issue:1 Volume:93 Page:47-57
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Arai Yasuyuki¹²,Kondo Tadakazu¹^ORCID,Shigematsu Akio³,Tanaka Junji⁴,Ohashi Kazuteru⁵,Fukuda Takahiro⁶,Hidaka Michihiro⁷,Kobayashi Naoki³,Iwato Koji⁸,Sakura Toru⁹,Onizuka Makoto¹⁰,Ozawa Yukiyasu¹¹,Eto Tetsuya¹²,Kurokawa Mineo¹³^ORCID,Kahata Kaoru¹⁴,Uchida Naoyuki¹⁵,Atsuta Yoshiko¹⁶¹⁷,Mizuta Shuichi¹⁸^ORCID,Kako Shinichi¹⁹

Affiliation:

1. Department of Hematology and Oncology; Graduate School of Medicine, Kyoto University; Kyoto Japan

2. Laboratory of Host Defenses; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bethesda Maryland

3. Department of Hematology; Sapporo Hokuyu Hospital; Sapporo Japan

4. Department of Hematology; Tokyo Women's Medical University; Tokyo Japan

5. Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center; Komagome Hospital; Tokyo Japan

6. Department of Hematopoietic Stem Cell Transplantation; National Cancer Center Hospital; Tokyo Japan

7. Department of Hematology; National Hospital Organization Kumamoto Medical Center, Kumamoto; Japan

8. Department of Hematology; Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital; Hiroshima Japan

9. Leukemia Research Center, Saiseikai Maebashi Hospital; Maebashi Japan

10. Department of Hematology/Oncology; Tokai University School of Medicine; Isehara Japan

11. Department of Hematology; Japanese Red Cross Nagoya First Hospital; Nagoya Japan

12. Department of Hematology; Hamanomachi Hospital; Fukuoka Japan

13. Department of Cell Therapy and Transplantation Medicine; The University of Tokyo Hospital; Tokyo Japan

14. Department of Hematology; Hokkaido University Hospital; Hokkaido Japan

15. Department of Hematology; Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital; Tokyo Japan

16. Japanese Data Center for Hematopoietic Cell Transplantation; Nagoya Japan

17. Department of Healthcare Administration; Nagoya University Graduate School of Medicine; Nagoya Japan

18. Department of Hematology; National Hospital Organization Toyohashi Medical Center; Toyohashi Japan

19. Division of Hematology; Jichi Medical University; Saitama Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology

Practical Research Project for Allergic Diseases and Immunology (Research Technology of Medical Transplantation)

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Hematology

Reference39 articles.

1. Allogeneic hematopoietic cell transplantation in adult patients with acute lymphoblastic leukemia;Marks;Hematol Oncol Clin North Am.,2014

2. Acute lymphoblastic leukaemia;Inaba;Lancet.,2013

3. Acute lymphoblastic leukemia in adults: encouraging developments on the way to higher cure rates;Mathisen;Leuk Lymphoma.,2013

4. High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study;Arai;Bone Marrow Transplant.,2016

5. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia;Shigematsu;Biol Blood Marrow Transplant.,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre‐transplant minimal residual disease on outcomes in high‐risk acute lymphoblastic leukemia patients in complete remission;Cancer Medicine;2024-01

2. Medium-dose etoposide, cyclophosphamide and total body irradiation conditioning potentiates anti-leukemia immunity in adults with acute lymphoblastic leukemia without aggravating graft-versus-host disease;Cytotherapy;2023-12

3. Pre-transplant phase angle as a potential marker for predicting the development of infection after allogeneic hematopoietic stem cell transplantation;Clinical Nutrition ESPEN;2023-12

4. Prognostic impact of complex and/or monosomal karyotypes in post‐transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach;British Journal of Haematology;2023-05-21

5. Total marrow lymphoid irradiation and cyclophosphamide is associated with low toxicity and good outcomes in patients undergoing hematopoietic stem cell transplantation for acute lymphoblastic leukemia and chronic myeloid leukemia in lymphoid blast crises – A phase I study;Clinical Transplantation;2023-05-05